Literature DB >> 23703657

Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice.

Guanhua Xie1, Gamze Karaca, Marzena Swiderska-Syn, Gregory A Michelotti, Leandi Krüger, Yuping Chen, Richard T Premont, Steve S Choi, Anna Mae Diehl.   

Abstract

UNLABELLED: Liver repair involves phenotypic changes in hepatic stellate cells (HSCs) and reactivation of morphogenic signaling pathways that modulate epithelial-to-mesenchymal/mesenchymal-to-epithelial transitions, such as Notch and Hedgehog (Hh). Hh stimulates HSCs to become myofibroblasts (MFs). Recent lineage tracing studies in adult mice with injured livers showed that some MFs became multipotent progenitors to regenerate hepatocytes, cholangiocytes, and HSCs. We studied primary HSC cultures and two different animal models of fibrosis to evaluate the hypothesis that activating the Notch pathway in HSCs stimulates them to become (and remain) MFs through a mechanism that involves an epithelial-to-mesenchymal-like transition and requires cross-talk with the canonical Hh pathway. We found that when cultured HSCs transitioned into MFs, they activated Hh signaling, underwent an epithelial-to-mesenchymal-like transition, and increased Notch signaling. Blocking Notch signaling in MFs/HSCs suppressed Hh activity and caused a mesenchymal-to-epithelial-like transition. Inhibiting the Hh pathway suppressed Notch signaling and also induced a mesenchymal-to-epithelial-like transition. Manipulating Hh and Notch signaling in a mouse multipotent progenitor cell line evoked similar responses. In mice, liver injury increased Notch activity in MFs and Hh-responsive MF progeny (i.e., HSCs and ductular cells). Conditionally disrupting Hh signaling in MFs of bile-duct-ligated mice inhibited Notch signaling and blocked accumulation of both MF and ductular cells.
CONCLUSIONS: The Notch and Hedgehog pathways interact to control the fate of key cell types involved in adult liver repair by modulating epithelial-to-mesenchymal-like/mesenchymal-to-epithelial-like transitions.
© 2013 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23703657      PMCID: PMC3758784          DOI: 10.1002/hep.26511

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  45 in total

1.  Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects.

Authors:  Sarbjit S Nijjar; Lorraine Wallace; Heather A Crosby; Stefan G Hubscher; Alastair J Strain
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

2.  Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation.

Authors:  Luika A Timmerman; Joaquín Grego-Bessa; Angel Raya; Esther Bertrán; José María Pérez-Pomares; Juan Díez; Sergi Aranda; Sergio Palomo; Frank McCormick; Juan Carlos Izpisúa-Belmonte; José Luis de la Pompa
Journal:  Genes Dev       Date:  2003-12-30       Impact factor: 11.361

Review 3.  Relationships among stellate cell activation, progenitor cells, and hepatic regeneration.

Authors:  Tania Roskams
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

4.  Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis.

Authors:  Andrew D Clouston; Elizabeth E Powell; Meagan J Walsh; Michelle M Richardson; A Jake Demetris; Julie R Jonsson
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

5.  Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis.

Authors:  Norihisa Ishimura; Steven F Bronk; Gregory J Gores
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

6.  Lunatic Fringe-mediated Notch signaling is required for lung alveogenesis.

Authors:  Keli Xu; Erica Nieuwenhuis; Brenda L Cohen; Wei Wang; Angelo J Canty; Jayne S Danska; Leigh Coultas; Janet Rossant; Megan Y J Wu; Tino D Piscione; Andras Nagy; Achim Gossler; Geoff G Hicks; Chi-Chung Hui; R Mark Henkelman; Lisa X Yu; John G Sled; Thomas Gridley; Sean E Egan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-11-06       Impact factor: 5.464

7.  Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis.

Authors:  Steve S Choi; Alessia Omenetti; Rafal P Witek; Cynthia A Moylan; Wing-Kin Syn; Youngmi Jung; Liu Yang; Debra L Sudan; Jason K Sicklick; Gregory A Michelotti; Marcos Rojkind; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-10-08       Impact factor: 4.052

8.  Efficient temporally-controlled targeted mutagenesis in smooth muscle cells of the adult mouse.

Authors:  Olivia Wendling; Jean-Marc Bornert; Pierre Chambon; Daniel Metzger
Journal:  Genesis       Date:  2009-01       Impact factor: 2.487

9.  The niche of stellate cells within rat liver.

Authors:  Iris Sawitza; Claus Kordes; Sven Reister; Dieter Häussinger
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

10.  Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation.

Authors:  F Long; X M Zhang; S Karp; Y Yang; A P McMahon
Journal:  Development       Date:  2001-12       Impact factor: 6.868

View more
  48 in total

Review 1.  Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.

Authors:  Luca Fabris; Romina Fiorotto; Carlo Spirli; Massimiliano Cadamuro; Valeria Mariotti; Maria J Perugorria; Jesus M Banales; Mario Strazzabosco
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08       Impact factor: 46.802

2.  Suppressor of Fused restraint of Hedgehog activity level is critical for osteogenic proliferation and differentiation during calvarial bone development.

Authors:  Jianying Li; Ying Cui; Jie Xu; Qihui Wang; Xueqin Yang; Yan Li; Xiaoyun Zhang; Mengsheng Qiu; Ze Zhang; Zunyi Zhang
Journal:  J Biol Chem       Date:  2017-08-09       Impact factor: 5.157

3.  Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.

Authors:  Savannah Tallino; Megan Duffy; Martina Ralle; María Paz Cortés; Mauricio Latorre; Jason L Burkhead
Journal:  J Nutr Biochem       Date:  2015-05-15       Impact factor: 6.048

4.  Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis.

Authors:  Varun Chandrashekaran; Suvarthi Das; Ratanesh Kumar Seth; Diptadip Dattaroy; Firas Alhasson; Gregory Michelotti; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Biochim Biophys Acta       Date:  2015-10-22

Review 5.  Notch in fibrosis and as a target of anti-fibrotic therapy.

Authors:  Biao Hu; Sem H Phan
Journal:  Pharmacol Res       Date:  2016-04-21       Impact factor: 7.658

Review 6.  Pathogenesis of Nonalcoholic Steatohepatitis.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2016-02-27       Impact factor: 22.682

7.  Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling.

Authors:  Kai Zhang; Yan-Qiong Zhang; Wen-Bing Ai; Qing-Ting Hu; Qiao-Juan Zhang; Lin-Yan Wan; Xiao-Lian Wang; Chang-Bai Liu; Jiang-Feng Wu
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

Review 8.  Molecular and cellular mechanisms of liver fibrosis and its regression.

Authors:  Tatiana Kisseleva; David Brenner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-30       Impact factor: 46.802

Review 9.  Mechanisms of hepatic stellate cell activation.

Authors:  Takuma Tsuchida; Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-10       Impact factor: 46.802

10.  A perspective on molecular therapy in cholangiocarcinoma: present status and future directions.

Authors:  Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Hepat Oncol       Date:  2014-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.